Comparative histopathologic evaluation of animal studies: Murine studies with L-tryptophan and constituents

Journal of Rheumatology

Volumn 23, Issue SUPPL. 46, 1996, Pages 99-110

  Brown, W Ray ^a  

^a Research Pathology Services   (United States)

Author keywords

1,1' ethylidenebis(tryptophan); 3 phenylamino alanine; comparative histopathology; eosinophilia myalgia syndrome; L tryptophan; mice

Indexed keywords

1,1' ETHYLIDENEBIS(TRYPTOPHAN); 3 (PHENYLAMINO)ALANINE; ALANINE DERIVATIVE; TRYPTOPHAN; UNCLASSIFIED DRUG; 1,1' ETHYLIDENE BIS(TRYPTOPHAN); 1,1'-ETHYLIDENE BIS(TRYPTOPHAN); 3-(PHENYLAMINO)ALANINE; ALANINE; DRUG DERIVATIVE;

ANIMAL EXPERIMENT; CONFERENCE PAPER; CONTROLLED STUDY; EOSINOPHILIA MYALGIA SYNDROME; HISTOPATHOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SKIN INJURY; ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG COMBINATION; DRUG EFFECT; MOUSE STRAIN; MUSCLE DISEASE; PATHOLOGY; SKELETAL MUSCLE; SKIN; SKIN DISEASE;

ALANINE; ANIMALS; DRUG COMBINATIONS; MICE; MICE, INBRED STRAINS; MUSCLE, SKELETAL; MUSCULAR DISEASES; SKIN; SKIN DISEASES; TRYPTOPHAN;

EID: 0030256984     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (5)

1. Eosinophilia-myalgia syndrome - New Mexico. MMWR Morb Mortal Wkly Rep 1989;38:765-7.
2. Eosinophilia-myalgia syndrome and L-tryptophan-containing products - New Mexico, Minnesota, Oregon, and New York. MMWR Morb Mortal Wkly Rep 1989;38:785-8.
3. Eosinophilia-myalgia syndrome associated with ingestion of L-tryptophan - United States as of January 9, 1990. MMWR Morb Mortal Wkly Rep 1990;39:14-5.
4. Silver RM, Ludwicka A, Hampton M, et al: A murine model of the eosinophilia-myalgia syndrome induced by 1,1′ethylidenebis (L-tryptophan). J Clin Invest 1994;93:1473-80.
5. Clauw DJ, Blank C, Tefft M, et al: Features of the eosinophilia-myalgia syndrome (EMS) in a mouse model (abstr). Arthritis Rheum 1993;(suppl 9)36:A100.